DayTwo provides personalized nutrition and actionable insights for people to maintain normal blood sugar levels based on their microbiome. Founded by Eran Elinav, Eran Segal, Lihi Segal, Marius Nacht, and Yuval Ofek in 2015, DayTwo is backed by investors that include aMoon Fund, Johnson & Johnson, Marius Nacht, Mayo Clinic, and Seventure Partners and is headquartered in Tel Aviv.